Alan Fisher's most recent trade in Neuphoria Therapeutics Inc. was a trade of 13,566 Restricted Stock Units done . Disclosure was reported to the exchange on April 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc | Alan Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Apr 2025 | 13,566 | 13,658 | - | - | Restricted Stock Units |